Soluble Tei2 fusion protein inhibits retinopathy of prematurity occurrence via regulation of the Ang/Tie2 pathway.

In conclusion, the combined regulation of the Ang/Tie2 and the vascular endothelial growth factor (VEGF)/VEGF receptor pathways markedly increased the efficacy of treatment with retinal neovascularization (RNV). Regulation of these pathways has a potential for treating RNV, in particular ROP. PMID: 31258697 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31258697?dopt=Abstract

Source: Experimental and Therapeutic Medicine - July 3, 2019 Category: General Medicine Tags: Exp Ther Med Source Type: research